Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5

25-plus yrs HPV vaccination impact wait + OxyContin maker Purdue Pharma is dissolved

#1
C C Offline
OxyContin maker Purdue Pharma is dissolved
https://consumer.healthday.com/oxycontin...80392.html

EXCERPTS: Purdue Pharma was dissolved on Wednesday and the Sackler family will pay $4.5 billion under a bankruptcy settlement that will end thousands of lawsuits brought against the company over the U.S. opioid crisis. Purdue was the maker of OxyContin, which was first brought to market in 1996. To date, more than 500,000 Americans have died of opioid overdoses.

However, the deal includes a controversial condition that largely absolves the Sacklers of liability, and they will remain among the richest families in the United States, The New York Times reported. As Judge Robert Drain [...] was frustrated that so much of the Sackler money was parked in offshore accounts. He said he had expected and wished for a higher settlement.

The lack of remorse from Sackler family members has been glaring: Last month, Richard Sackler, former president and co-chairman of the company's board, testified that the family, the company, and its products bore no responsibility for the opioid epidemic. Other Sacklers struck a more conciliatory note, but none apologized or took personal responsibility... (MORE - details)


HPV vaccination will reduce throat and mouth cancers, but overall impact will take 25-plus years to see
https://www.eurekalert.org/news-releases/927322

INTRO: Vaccinations against human papillomavirus (HPV), a major cause of throat and back of mouth cancers, are expected to yield significant reductions in the rates of these cancers in the U.S., but will not do so until after 2045, according to a new modeling study from researchers at the Johns Hopkins Bloomberg School of Public Health.

HPV is the most common sexually transmitted infectious virus worldwide. HPV infections are often silent, and while most infections clear, some are chronic and can trigger cancers including mouth and throat (oropharyngeal), and cervical cancer because they disrupt DNA and inhibit tumor-suppressor proteins in the cells they infect. Although there is no cure for existing HPV infections, new infections are preventable with vaccines, the first of which entered use in the U.S. in 2006.

In the new study, the Bloomberg School researchers analyzed national databases on oropharyngeal cancer cases and HPV vaccinations, and projected the impact of HPV vaccination on the rates of these cancers in different age groups. They estimated that the oropharyngeal cancer rate would nearly halve between 2018 and 2045 among people ages 36–45. However, they also projected that the rate in the overall population would stay about the same from 2018-2045, due to still-rising rates of these cancers in older people, where most of these cancers occur.

The study appears online September 2 in JAMA Oncology.

“We estimate that most of the oropharyngeal cancers from 2018 to 2045 will occur among people who are 55 years and older and have not been vaccinated,” says study lead author Yuehan Zhang, a PhD candidate in the research group of Gypsyamber D’Souza, PhD, professor in the Department of Epidemiology at the Bloomberg School.

“HPV vaccination is going to work to prevent oropharyngeal cancers, but it will take time to see that impact, because these cancers mostly occur in middle age,” D’Souza says.

Oropharyngeal cancer is the most common HPV-related cancer, and according to the Oral Cancer Foundation there are more than 50,000 new cases of it in the U.S. each year. Alcohol and tobacco use also are risk factors, but are seen as increasingly less important than HPV.

Vaccination is a powerful medical weapon against this family of viruses, but has one major shortcoming: It can prevent, but not treat. In other words, it does not work against established HPV infections or against cells that have been transformed by HPV and are on their way to forming tumors. Thus it is recommended chiefly for the young who are not yet exposed to sexually transmitted HPV. (Most people who were already adults when HPV vaccination became available have never been vaccinated, and thus remain at risk for these cancers.) (MORE)
Reply


Possibly Related Threads…
Thread Author Replies Views Last Post
  Research Skeletons in the closet of Big Pharma + Acetaminophen linked to language delays in... C C 0 39 Jan 4, 2024 07:05 PM
Last Post: C C
  Psychedelics plus psychotherapy can spark rapid changes in brain (mind pharmacology) C C 0 68 Oct 6, 2023 04:25 PM
Last Post: C C
  Article Commercialization of cannabis linked to increased traffic injuries + 1 in 3 have HPV C C 0 70 Sep 6, 2023 04:32 PM
Last Post: C C
  Article What the “Big Pharma” accusation gets right (and wrong) about the drug industry C C 0 62 May 30, 2023 09:33 AM
Last Post: C C
  Hearts from donors who used illicit drugs or overdosed safe for transplant, cuts wait C C 0 86 Jul 28, 2021 08:24 PM
Last Post: C C
  Pharma looks to outer space to boost drug R&D C C 0 144 Dec 10, 2020 07:18 PM
Last Post: C C
  Purdue seeking bankruptcy protection Leigha 4 436 Sep 17, 2019 09:04 PM
Last Post: Leigha
  Why Americans hate Big Pharma more than ever C C 1 246 Sep 11, 2019 05:34 AM
Last Post: Magical Realist
  Too much B6 & B12 = hip fractures? + Pharma's high prices not devoted to research? C C 0 378 May 16, 2019 04:41 AM
Last Post: C C
  For 1st time, feds criminally charge pharma for opioid epidemic C C 1 570 Apr 25, 2019 01:34 AM
Last Post: RainbowUnicorn



Users browsing this thread: 1 Guest(s)